238000000513 principal component analysis Methods 0.000 description 8.238000000695 excitation spectrum Methods 0.000 claims description 5.230000000875 corresponding Effects 0.000 claims description 8.238000000034 method Methods 0.000 claims abstract description 49.238000001228 spectrum Methods 0.000 claims abstract description 99.230000005284 excitation Effects 0.000 claims abstract description 104.238000003384 imaging method Methods 0.000 title claims description 104.230000003595 spectral Effects 0.000 title claims abstract description 107. ![]() Publication of US20080051665A1 publication Critical patent/US20080051665A1/en Application granted granted Critical Publication of US10335038B2 publication Critical patent/US10335038B2/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US84024706P priority Critical Application filed by Xenogen Corp filed Critical Xenogen Corp Priority to US11/844,920 priority patent/US10335038B2/en Assigned to XENOGEN CORPORATION reassignment XENOGEN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Xenogen Corp Priority date (The priority date is an assumption and is not a legal conclusion. ![]() Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Heng Xu Bradley Rice Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US11/844,920 Other versions US10335038B2 Google Patents US20080051665A1 - Spectral unmixing for in-vivo imaging US20080051665A1 - Spectral unmixing for in-vivo imaging
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |